Cargando…
Chemotherapy vs. Immunotherapy in combating nCOVID19: An update
The nCOVID-19 pandemic initiated its course of contagion from the city of Wuhan and now it has spread all over the globe. SARS-CoV-2 is the causative virus and the infection as well as its symptoms are distributed across the multi-organ perimeters. Interactions between the host and virus governs the...
Autores principales: | Choudhury, Abhigyan, Mukherjee, Gargi, Mukherjee, Suprabhat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130497/ https://www.ncbi.nlm.nih.gov/pubmed/34020832 http://dx.doi.org/10.1016/j.humimm.2021.05.001 |
Ejemplares similares
-
The nCOVID-19 and financial stress in the USA: health is wealth
por: Alola, Andrew Adewale, et al.
Publicado: (2020) -
Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein
por: Mukherjee, Shruti, et al.
Publicado: (2021) -
Coronavirus nCOVID-19: A pandemic disease and the Saudi precautions
por: Perveen, Shagufta, et al.
Publicado: (2020) -
nCOVID-19 Pandemic: From Molecular Pathogenesis to Potential Investigational Therapeutics
por: Kabir, Md. Tanvir, et al.
Publicado: (2020) -
Evaluating the evidence for direct central nervous system invasion in patients infected with the nCOVID-19 virus
por: Lekgwara, Patrick, et al.
Publicado: (2020)